NVWM LLC’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.02M | Sell |
1,813
-10
| -0.5% | -$6.41K | 0.23% | 126 |
|
|
2025
Q4 | $1.23M | Sell |
1,823
-33
| -2% | -$22.5K | 0.27% | 112 |
|
|
2025
Q3 | $1.19M | Sell |
1,856
-18
| -1% | -$10.9K | 0.27% | 112 |
|
|
2025
Q2 | $1.01M | Sell |
1,874
-10
| -0.5% | -$4.78K | 0.24% | 126 |
|
|
2025
Q1 | $791K | Buy |
1,884
+3
| +0.2% | +$1.3K | 0.21% | 139 |
|
|
2024
Q4 | $778K | Sell |
1,881
-3
| -0.2% | -$1.32K | 0.2% | 147 |
|
|
2024
Q3 | $952K | Sell |
1,884
-4
| -0.2% | -$1.94K | 0.24% | 132 |
|
|
2024
Q2 | $920K | Buy |
1,888
+108
| +6% | +$54.2K | 0.24% | 128 |
|
|
2024
Q1 | $961K | Buy |
1,780
+46
| +3% | +$25.1K | 0.26% | 120 |
|
|
2023
Q4 | $962K | Sell |
1,734
-42
| -2% | -$19.7K | 0.29% | 106 |
|
|
2023
Q3 | $777K | Sell |
1,776
-262
| -13% | -$131K | 0.25% | 123 |
|
|
2023
Q2 | $1.02M | Buy |
2,038
+151
| +8% | +$72.4K | 0.33% | 92 |
|
|
2023
Q1 | $944K | Sell |
1,887
-43
| -2% | -$20.6K | 0.32% | 94 |
|
|
2022
Q4 | $787K | Sell |
1,930
-8
| -0.4% | -$3.1K | 0.29% | 106 |
|
|
2022
Q3 | $631K | Sell |
1,938
-37
| -2% | -$13.6K | 0.25% | 127 |
|
|
2022
Q2 | $692K | Hold |
1,975
| – | – | 0.27% | 125 |
|
|
2022
Q1 | $1.08M | Sell |
1,975
-29
| -1% | -$15.3K | 0.34% | 97 |
|
|
2021
Q4 | $1.32M | Buy |
2,004
+161
| +9% | +$101K | 0.41% | 82 |
|
|
2021
Q3 | $1.15M | Buy |
1,843
+7
| +0.4% | +$4.7K | 0.41% | 85 |
|
|
2021
Q2 | $1.16M | Buy |
1,836
+7
| +0.4% | +$3.87K | 0.42% | 78 |
|
|
2021
Q1 | $895K | Sell |
1,829
-615
| -25% | -$308K | 0.36% | 103 |
|
|
2020
Q4 | $1.22M | Sell |
2,444
-734
| -23% | -$328K | 0.51% | 59 |
|
|
2020
Q3 | $1.25M | Sell |
3,178
-136
| -4% | -$50.3K | 0.59% | 52 |
|
|
2020
Q2 | $1.09M | Sell |
3,314
-18
| -0.5% | -$5.21K | 0.59% | 51 |
|
|
2020
Q1 | $807K | Buy |
3,332
+286
| +9% | +$74.6K | 0.56% | 48 |
|
|
2019
Q4 | $795K | Sell |
3,046
-426
| -12% | -$112K | 0.48% | 63 |
|
|
2019
Q3 | $944K | Sell |
3,472
-7
| -0.2% | -$1.95K | 0.58% | 44 |
|
|
2019
Q2 | $958K | Buy |
3,479
+299
| +9% | +$73.7K | 0.58% | 42 |
|
|
2019
Q1 | $711K | Buy |
3,180
+151
| +5% | +$31.2K | 0.47% | 58 |
|
|
2018
Q4 | $563K | Buy |
3,029
+1,021
| +51% | +$209K | 0.42% | 75 |
|
|
2018
Q3 | $501K | Buy |
2,008
+128
| +7% | +$31.1K | 0.32% | 103 |
|
|
2018
Q2 | $410K | Buy |
+1,880
| New | +$387K | 0.28% | 112 |
|
Other funds holding IDXX
VCM
VPM
NVWM LLC's IDXX Position: Q1 2026 in Review
NVWM LLC reduced its Idexx Laboratories (IDXX) stake by 0.55% in Q1 2026, selling an estimated $6.41K and leaving 1,813 shares worth $1.02M. The position accounts for 0.23% of the portfolio, ranked #126.
NVWM LLC first reported a position in IDXX in Q2 2018 and has held it in 32 quarters since. The position peaked at $1.32M in Q4 2021. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.
- NVWM LLC held 1,813 shares of Idexx Laboratories worth $1.02M as of Q1 2026.
- NVWM LLC sold 10 Idexx Laboratories shares in Q1 2026, an estimated $6.41K.
- Idexx Laboratories made up 0.23% of NVWM LLC's portfolio in Q1 2026, its #126 holding.
- NVWM LLC first reported a position in Idexx Laboratories in Q2 2018 and has held it in 32 quarters since.
- NVWM LLC's Idexx Laboratories position peaked at $1.32M in Q4 2021.
- 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.
Based on NVWM LLC's 13F filing for Q1 2026, filed 27 Apr 2026.